diabetestalk.net

Ascensia Diabetes Care Uk

3 Peaks, 33 Participants 24 Hours: Ascensia Diabetes Care Staff Team Complete Three Peaks Challenge

3 Peaks, 33 Participants 24 Hours: Ascensia Diabetes Care Staff Team Complete Three Peaks Challenge

3 Peaks, 33 participants 24 hours: Ascensia Diabetes Care staff team complete Three Peaks Challenge 3 Peaks, 33 participants 24 hours: Ascensia Diabetes Care staff team complete Three Peaks Challenge A team of Ascensia Diabetes Care staff members have raised funds for JDRF by completing the celebrated Three Peaks Challenge.The group comprised of 33 participants from across the UK in the successful bid to conquer England, Wales and Scotlands highest peaks, in just 24 hours. Left to right: Neeraj Kibe, Richard Wrighte, Catriona Rasman, Ros Barker, Talwinder Nagra With a passion for helping those living with this condition, the Ascensia team wanted to take on a significant challenge that could raise funds to support people with type 1 diabetes. The group aimed to raise 5,000 after completing the three climbs which covered a total of 42km horizontal distance and 3000 vertical metres! Left to right: Ben Letcher, Robert Gilkes, Richard Wrighte, Catherine Kulle, Ros Barker, Talwinder Nagra, Nicholas Cull, Catriona Rasman, Phil Shaffner, Neeraj Kibe Ascensia Diabetes Care was established in 2016 as a global specialist diabetes care company, after Panasonic Healthcare Holdings acquired Bayer Diabetes Care and set it up as a new stand-alone business. Elie Kelpie, Senior Corporate Fundraising Manager at JDRF in the UK said: Were delighted the team from Ascensia Diabetes Care is raising funds for JDRF and are very grateful for their stellar efforts. Their commitment to this fantastic fundraising challenge and to the diabetes community is admirable and will help JDRF support vital type 1 diabetes research. The team has raised a wonderful amount -the current total raised including Gift Aid is over5,780! Every penny will help support JDRF research to cure, treat and prevent type 1 di Continue reading >>

Contour Diabetes App (uk) On The Appstore

Contour Diabetes App (uk) On The Appstore

This pair of the glucose tester (BG meter) has been a big improvement from the digital LCD meters I have been using. The meter/tester is basically an iPhone sensor this explains its simplicity. The app provides ample functionality but is limited and confined. It wouldve extended its reach exponentially if only it opened itself to other applications e.g. Apples native Health app and other Diabetes apps, which I dont quite get because their main business is the meter the app is a compliment. The more apps that can access the contour app data the more people would get the meter to use with their preferred applications. I sincerely hope Contour App is going to open its doors in the immediate future. One thing I would like to mention though it has nothing to do with the app, the microlet lancets are very well made and are extremely sharp this equates to little or no pain. This app has amazing potential but it just isnt reliable enough to be useful. Ive been using this since it launched on 2 different phones and it just is far too glitchy to rely on. The main issue for me is connectivity between the meter and phone. To start with it was perfect then after the first update it just constantly lost connection. The faff of pairing it all the time got boring quickly. When I moved to the new phone I thought maybe the issue would be resolved but no. I have had to reinstall several times and still it refuses. Im most likely going to switch to a different meter thats more self contained. Its irritating because honestly Im not going to be writing readings down on paper or a spreadsheet, who has the time for that, so the consultant will be sulking shortly, course hes more than welcome to spend hours of his life transcribing results and making a graph if he feels the urge! This app has Continue reading >>

Ascensia Diabetes Challenge

Ascensia Diabetes Challenge

Do you have a digital solution for the global epidemic oftype 2 diabetes? Ascensia Diabetes Care has partnered with yet2 to launch the Ascensia Diabetes Challenge A GLOBAL INNOVATION COMPETITION. Weare seeking submissions for innovative digital solutions that can genuinely change behavior and improve the lives of people with type 2 diabetes. We want to support companies who are developing the next big leap forward in digital solutions for self-management of type 2 diabetes. The six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge have been announced. The six finalists were selected from 116 submissions and chosen by a panel of external experts and members of the Ascensia Medical, R&D and Commercial teams. The selected entrants will receive 10,000 Euros for reaching this stage and are due to present their solutions at the finalist event in April to determine the winner. For more information, visit: www.ascensia.com/press/ . The Ascensia Diabetes Challenge has now closed for entries. Thank you to all the startups and entrepreneurs that submitted. Our judges will be reviewing the entries and selecting up to six finalists who will each receive a cash prize and be invited to our finalist event. Please check back later in March to hear who has reached the finalist stage. Submissions deadline now February 23, 2018 Entrants now have until Friday February 23, 2018 to submit their innovative, patient-centric, digital solutions to support diabetes management. Submit your entry for the Ascensia Diabetes Challenge below. Two new judges that have been announced for the Ascensia Diabetes Challenge. Healthcare innovation experts Dr Neal Kaufman, USA, and Dr Sidney Yee, Singapore, have both joined the judging panel for the competition. This comes as t Continue reading >>

Ascensia Diabetes Care Launches Contour Next One Blood Glucose Monitoring System In Uk

Ascensia Diabetes Care Launches Contour Next One Blood Glucose Monitoring System In Uk

Ascensia Diabetes Care launches CONTOUR NEXT ONE blood glucose monitoring system in UK Ascensia Diabetes Care has launched the CONTOUR NEXT ONE blood glucose monitoring system (BGMS) in the UK. The CONTOUR NEXT ONE BGMS features an easy-to-use, wireless-enabled smart CONTOUR NEXT ONE meter that connects to a smart mobile device via Bluetooth. The meter provides an immediate feedback while seamlessly connecting to the CONTOUR DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. This app then combines the results with other data recorded by users to generate a detailed report on their condition. The report helps patients in understanding how the disease is impacting their regular life, thereby paving the way for a better management of the ailment. Patients can also share the report with their healthcare professional through the app either in advance or on the day of their appointment, helping to create more informed discussions. Portsmouth Hospitals NHS Trust diabetes and endocrinology consultant Dr Partha Kar said: People with diabetes are turning to mobile devices to help manage and track their condition. They want solutions that seamlessly integrate into their lives and present their readings in a simple and intuitive way. "The CONTOUR NEXT ONE system appears to be a development for interconnected diabetes management that has the potential to engage more people with diabetes in their treatment plans, which could lead to better outcomes. "The CONTOUR NEXT ONE blood glucose meter has demonstrated consistently remarkable levels of accuracy and precision for patients." Additional features of the meter are the smartLIGHT to offer instant feedback on blood glucose readings and the Second-Chance sampling, which prompts reap Continue reading >>

Bayer Diabetes Care - Berkshire - Rg14 1ja

Bayer Diabetes Care - Berkshire - Rg14 1ja

Bayer Diabetes Care is a leading provider of home blood glucose testing kits, such as the popular Contour and Breeze ranges and the interactive Didget meter for children. Bayer's Contour USB is the world's first blood glucose meter with plug and play diabetes management software. The meters in Bayer's range require no coding in order to calibrate the test strips for use in the meter. So without the need for coding, Bayer's meters allow for greater ease of use and less worrying about whether the test will be accurate. Glucofacts Deluxe is Bayer's diabetes management software. Connect your Bayer meter to your computer or laptop and you can view, analyse and print off your results. Glucofacts Deluxe is compatible with all Bayer's meters and is available onboard the Contour USB. From Monday to Friday, Bayer Diabetes Support is available for owners of Bayer meters to call for guidance and support. The service is staffed by qualified nurses who are there to help you. No query is too trivial. You can contact Bayer Diabetes Care on the following: Continue reading >>

Introducing Ascensia Diabetes Care

Introducing Ascensia Diabetes Care

The first convenient test for sugars in urine (tablet). The first 'dip and read' test strip for glucose in urine. The first test strip for glucose in blood. 1969 - Ames Reflectance Meter from Miles Laboratories Ltd The first blood glucose meter with a results memory. The first blood glucose meter with event markers and computer interface. The first PC application for analysing blood glucose data in a clinic environment. The first telephone link-up with a blood glucose meter. The first capillary draw biosensor for blood glucose monitoring. The first reagent cartridge system for self-blood glucose monitoring. The first lancing device designed to enable sample acquisition from alternative body sites. No Coding technology is launched and is combined with an on-board disc of test strips in the Ascensia BREEZE blood glucose meter. The UK launches the first single strip meter to use No Coding technology. Continuing to build on already successful products, enhanced versions of both the CONTOUR meter and BREEZE 2 in 2007 is launched to provide faster test times and smaller blood samples. CONTOUR launches innovative new blood glucose meter which wirelessly transmits blood glucose test results to compatible Medtronic insulin pumps, making insulin dosing easier than ever for patients on insulin pump therapy. DIDGET is launched, the first blood glucose meter to reward children for consistent testing. The CONTOUR USB, the world's first meter with plug and play diabetes management software, is launched in the UK and Ireland. 2012 - CONTOURXT meter and CONTOUR NEXT test strips The CONTOURXT meter and CONTOUR NEXT test strips, using new innovative technology to offer next generation accuracy to people with diabetes in the UK is launched. 2013 - CONTOURNEXT USB, CONTOURNEXT LINK Meter T Continue reading >>

Ascensia Around You Programme

Ascensia Around You Programme

When you register a CONTOUR meter, you automatically become part of the Customer support programme by Ascensia, which gives you access to a range of benefits including: Access to Ascensia Diabetes Support. Our qualified nurses and customer care advisors use their professional expertise and experience to offer advice and information you can trust. No query is too trivial. When in doubt, just call 0345 600 6030 (UK) 8am to 8pm Monday to Friday. Free warranty replacement meter should the need arise. Free record diaries and control solution. Free GLUCOFACTSDELUXE diabetes management software. Register today by calling Ascensia Diabetes Care Support on 0345 600 6030 (Mon-Fri, 8.00am - 8.00pm) The information on this site is intended to provideyou with information about Ascensia DiabetesCares products and is not a substitute forprofessional medical advice or treatment forspecific medical conditions. Any questions orconcerns you have regarding diabetes or a medicalcondition should always be discussed with aqualified medical professional. Cookies on the Ascensia Diabetes Care website: We use cookies and similar technologies on our website. Our privacy policy provides additional information on how we use cookies and how you can disable or change your cookie settings. Continue reading >>

Ascensia Diabetes Care - About Us!

Ascensia Diabetes Care - About Us!

Established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings, Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health. We are determined to continue developing our line of products, beyond our current CONTOURportfolio of meters, so that Ascensia Diabetes Care is the recognized world leader in delivering convenient, easy-to-use blood glucose monitoring systems and testing supplies. We collaborate closely with healthcare professionals and other partners to ensure our products meet the high standards of accuracy to help people with diabetes manage their condition, regardless of type of diabetes, stage of disease or frequency of testing required. Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes and enable them to live richer lives. At Ascensia Diabetes Care we want to serve the needs of patients through our innovation and specialist expertise in diabetes. We create high quality solutions and precision ools that help patients manage their diabetes and take charge of their lives. We are proud of our heritage as a leading provider of solutions for diabetes care. We will continue to build on the legacy of our longstanding commitment to diabetes The UK Headquarters for Ascensia Diabetes Care is in Berkshire, UK. The information on this site is intended to provideyou with information about Ascensia DiabetesCares products and is not a substitute forprofessional medical advice or treatment forspecific medical conditions. Any questions orconcerns you have regarding diabetes or a medicalcondition should always be discussed with aqualified medical professional. Cookies on the Ascensia Di Continue reading >>

Ascensia Diabetes Launches Updated Diabetes Management App

Ascensia Diabetes Launches Updated Diabetes Management App

Ascensia Diabetes launches updated diabetes management app Today Ascensia Diabetes Care UK launched the latest version of its Contour Diabetes app, a tool that helps people self-manage their diabetes, in the UK and Ireland. The app is designed to connect to the companys Contour One Next blood glucose meter. This latest upgrade to the Contour Diabetes app provides patients with a smarter tool that can help to make the self-management of their diabetes easier, Ros Barker, country head of UK and Ireland for Ascensia Diabetes Care, said in a statement. At Ascensia we are listening to feedback from people with diabetes about their needs, and are continuing to invest in the further development of the Contour Diabetes app, so that we can provide solutions that make diabetes self-management better, easier, and smarter. The new version of the app will include a feature called My Patterns, which helps identify suboptimal patterns in blood glucose results. The company says this feature will help users improve their patterns by giving them reminders and testing plans. The feature will also provide users with possible causes for the suboptimal pattern, and resources for how to address the issue. The new version will also feature 11 different test reminder plans, the ability to view insulin doses and carb intake next to to blood glucose readings, a blood sugar diary, and the ability to export data as a CSV file. In 2016, Ascensia Diabetes Care received FDA clearance for Contour Next One, which has the ability to connect to both the latest Contour Diabetes app and the previous one. It officially launched in the US in 2017. Self-management is critical in diabetes. One of the keys to effective diabetes self-management for patients is to provide them with tools that can help them to und Continue reading >>

Ascensia Diabetes Care Launches Smarter Version Of Contour®diabetes App With New Features To Support Self-management

Ascensia Diabetes Care Launches Smarter Version Of Contour®diabetes App With New Features To Support Self-management

Newbury, United Kingdom, 12th December, 2017 - Today, Ascensia Diabetes Care has announced the launch of its upgraded version of the CONTOUR®DIABETES app in the United Kingdom and Ireland. It includes the new My Patterns feature, which can more intelligently analyse blood glucose results received from the CONTOUR®NEXT ONE meter, providing personalised meaningful feedback to help improve diabetes self-management for patients. This new release will be available from today in the Apple App Store (iOS) and Google Play (Android). The CONTOUR®DIABETES app seamlessly connects to the CONTOUR®NEXT ONE blood glucose meter. The My Patterns feature on the upgraded CONTOUR®DIABETES app analyses data received from the meter to identify and notify the user of sub-optimal patterns in their blood glucose readings. Once it has notified the user that a pattern has been identified, the CONTOUR®DIABETES app will prompt users about the possible causes of the pattern and provide guidance to help address it. It allows patients to set reminders or use testing plans to help improve their sub-optimal blood glucose patterns, and will track their progress to see if the pattern improves over time. The latest version of the app includes the ability to recognise 14 different patterns and includes 11 different structured testing plans. The app will continue to evolve in the future to include additional patterns and testing plans, as well as adding new features and functionality. My Patterns has been developed using behavioural science concepts and is based on the Information, Motivation and Behavioural Skills model for chronic diseases that was pioneered by psychologist Dr William Fisher. The basis of this model is that people with diabetes need actionable information, motivation to act on that i Continue reading >>

Ascensia Diabetes Care Holdings Ag Key Developments

Ascensia Diabetes Care Holdings Ag Key Developments

Key Executives for Ascensia Diabetes Care Holdings AG Ascensia Diabetes Care Holdings AG does not have any Key Executives recorded. Ascensia Diabetes Care Holdings AG Key Developments Ascensia Diabetes Care Announces Commercial Agreement with DexCom, Inc. to Include CONTOURNEXT ONE BGMS with the Dexcom G5 Continuous Glucose Monitoring System for Patients Covered by Medicare Ascensia Diabetes Care announced that it has entered into an agreement with DexCom Inc. to provide the highly accurate Ascensia CONTOURNEXT ONE blood glucose monitoring system (BGMS) as part of the Dexcom G5 CGM System Medicare offering. The complete bundle will be available to people with diabetes who are covered by Medicare and qualify for therapeutic CGM. Dexcom G5 is currently the only CGM system approved by the FDA to meet the criteria for therapeutic CGM. Under the terms of the agreement, Ascensia Diabetes Care's CONTOURNEXT ONE BGMS will be provided to eligible people with diabetes in the bundle of supplies for the Dexcom G5 CGM System. The role of the CONTOURNEXT ONE BGMS will be to provide highly accurate readings for CGM calibration. The Dexcom G5 CGM System provides dynamic glucose information by showing a user his or her glucose level, along with both trend and rate of change information. People who use the G5 CGM System calibrate regularly to verify the CGM sensor reading is on track. Ascensia Diabetes Care and Voluntis Announce Technology Partnership to Help Optimize Insulin Management for People with Type 2 Diabetes Ascensia Diabetes Care and Voluntis announced a global technology partnership designed to help improve the lives of people with Type 2 diabetes by optimizing insulin management. This collaboration will connect the Voluntis basal insulin management solution for people with Continue reading >>

Whisk's Ai-powered Culinary Coach Named As Winner Of Ascensia Diabetes Challenge - Endocrine News

Whisk's Ai-powered Culinary Coach Named As Winner Of Ascensia Diabetes Challenge - Endocrine News

Whisks AI-Powered Culinary Coach Named as Winner of Ascensia Diabetes Challenge During the American Diabetes Associations 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care revealed that UK-based Whisk was selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management. Whisks winning innovation is a Culinary Coach that uses artificial intelligence (AI) to provide personalized food recommendations based on flavor preferences and food avoidance, that will be expanded to use blood glucose data for people with diabetes. Whisk presented their winning solution to the diabetes community for the first time at the 2018 DiabetesMine D-Data Exchange Event in Orlando. The Whisk platform is an AI-powered nutrition platform that currently enables users to browse recipes based on factors including their personal taste preferences, time constraints, budgets, weather and dietary restrictions or allergies. Once a user adds a recipe to their meal plan, it can be automatically added to an online shopping cart at some of the worlds leading grocery retailers, seamlessly allowing them to buy ingredients. As winner of the challenge, Whisk plan to create a personalized food experience for people with type 2 diabetes that will learn from their blood glucose readings and make food recommendations that are more tailored to their own diabetes. Using readings from Ascensias blood glucose monitoring systems, the AI will learn how the users blood glucose readings react to specific foods and recipes, allowing them to build a tailored meal plan for their diabetes that can help to keep their blood glucose in range. The Culinary Coach for diabetes will start by providing personalized Continue reading >>

Introducing Ascensia Diabetes Care

Introducing Ascensia Diabetes Care

The first convenient test for sugars in urine (tablet). The first 'dip and read' test strip for glucose in urine. The first test strip for glucose in blood. 1969 - Ames Reflectance Meter from Miles Laboratories Ltd The first blood glucose meter with a results memory. The first blood glucose meter with event markers and computer interface. The first PC application for analysing blood glucose data in a clinic environment. The first telephone link-up with a blood glucose meter. The first capillary draw biosensor for blood glucose monitoring. The first reagent cartridge system for self-blood glucose monitoring. The first lancing device designed to enable sample acquisition from alternative body sites. No Coding technology is launched and is combined with an on-board disc of test strips in the Ascensia BREEZE blood glucose meter. The UK launches the first single strip meter to use No Coding technology. Continuing to build on already successful products, enhanced versions of both the CONTOUR meter and BREEZE 2 in 2007 is launched to provide faster test times and smaller blood samples. CONTOUR launches innovative new blood glucose meter which wirelessly transmits blood glucose test results to compatible Medtronic insulin pumps, making insulin dosing easier than ever for patients on insulin pump therapy. DIDGET is launched, the first blood glucose meter to reward children for consistent testing. The CONTOUR USB, the world's first meter with plug and play diabetes management software, is launched. 2012 - CONTOURXT meter and CONTOUR NEXT test strips The CONTOURXT meter and CONTOUR NEXT test strips, using new innovative technology to offer next generation accuracy to people with diabetes is launched. 2013 - CONTOURNEXT USB, CONTOURNEXT LINK Meter The CONTOUR NEXT USB and CONTOUR Continue reading >>

Home | Contour Next One | Ascensia Diabetes Care

Home | Contour Next One | Ascensia Diabetes Care

Set remindersto test and add your appointment with your Healthcare Professional to your diary. Getting accurate Blood Glucose (BG) results Simple to usethe CONTOURNEXT ONE meter has been shown to deliver remarkably accurate blood glucose results to enable you to make the best decisions. Accuracy standards allow blood glucose results taken on a meter to vary 15% from a blood glucose test done in a laboratory.* The CONTOURNEXT ONE meter exceeds the standards are 8.4%1-2which gives you a result even closer to laboratory reference. *EN ISO 15197:2015 accuracy requirements (Section 6.3 & Section 8) for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples are that at least 95% of results shall fall within 0.83 mmol/L or 15% of the reference result of the mean YSI reference for samples with glucose concentrations <5.55 mmol/L and 5.55 mmol/L, respectively. 1. Christiansen M et al. Accuracy and user performance evaluation of a new blood glucose monitoring system in development for use with CONTOURNEXT test strips. Poster presented at the 15th annual meeting of the Diabetes Technology Society (DTS); October 22-24, 2015; Bethesda, Maryland. USA. 2. International Organization for Standardization. In vitro diagnostic test systems Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2015. WithSecond-Chance samplingyou can reapply more blood to the same test strip if the first sample is insufficient. This helps to avoid the need for repeat finger pricking and wasting test strips. ThesmartLIGHTfeature provides you with instant feedback on your blood glucose results indicating if your blood glucose results are above, within or Continue reading >>

Contour Next Link 2.4 Blood Glucose Meter

Contour Next Link 2.4 Blood Glucose Meter

Bolus dosing at the touch of a button: send a manual or preset bolus dose directly from the CONTOUR NEXT LINK 2.4 meter to your MiniMed 640G insulin pump. Calibrates automatically with your continuous gluocse monitoring (CGM) system from Medtronic, if you use a CGM device. Use your CONTOUR NEXT LINK 2.4 meter to upload your pump data to CareLink™, Medtronic's therapy management software. Exceptional accuracy for results you can count on: Uses CONTOUR NEXT test strips for high accuracy. Find out more about the highly accurate CONTOUR NEXT LINK test strips by visiting the Ascensia Diabetes Care website. No Coding technology removes the need to manually code the meter before testing, eliminating errors due to miscoding. MultiPulse technology from Ascensia Diabetes Care ensures accurate glucose measurements, even when blood glucose levels are low.* Accuracy is not affected by many common interfering substances (for detailed information, please refer to package insert). Accurate readings can help you adjust your insulin bolus dose more confidently. A modern design with multiple features for ease of use and discretion Smart, stylish and compact with readings after a 5 second countdown. Easy to use and convenient. Second-Chance™ sampling tells you when to apply more blood if the first sample was not enough. Click here to view the CONTOUR NEXT LINK 2.4 meter demo If you are using the MiniMed™ 640G insulin pump, you will automatically receive the CONTOUR NEXT LINK 2.4 meter with your pump. If you have another Medtronic insulin pump or CGM system, Ascensia Diabetes Care also offers the CONTOUR NEXT LINK blood glucose meter, which wirelessly connects to the Paradigm Veo™ insulin pump, the MiniMed REAL-Time insulin pump and the Guardian™ REAL-Time CGM system. Visit the As Continue reading >>

More in diabetes